Tesla
TSLA
NVIDIA
NVDA
Micron Technology
MU
4
Meta Platforms
META
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
SABS SAB Biotherapeutics
- 1.750
- +0.250+16.67%
Close Apr 25 16:00 ET
16.26MMarket Cap-0.48P/E (TTM)
1.750High1.440Low47.10KVolume1.560Open1.500Pre Close75.14KTurnover0.73%Turnover RatioLossP/E (Static)9.29MShares5.01052wk High0.63P/B11.26MFloat Cap1.00052wk Low--Dividend TTM6.43MShs Float129.000Historical High--Div YieldTTM20.67%Amplitude1.000Historical Low1.595Avg Price1Lot Size
SAB Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 12.70%42.91M | -46.97%10.01M | 112.47%11.31M | 57.52%10.2M | 53.89%11.39M | 31.67%38.08M | 140.12%18.87M | -31.82%5.32M | -1.01%6.48M | 10.36%7.4M |
| Selling and administrative expenses | -41.25%13.98M | -83.39%2.47M | 35.33%3.48M | 25.61%3.64M | 21.52%4.19M | 45.27%23.8M | 416.22%14.88M | -36.44%2.57M | -32.70%2.9M | -33.53%3.45M |
| -General and administrative expense | -41.25%13.98M | -83.39%2.47M | 35.33%3.48M | 25.61%3.64M | 21.52%4.19M | 45.27%23.8M | 416.22%14.88M | -36.44%2.57M | -32.70%2.9M | -33.53%3.45M |
| Research and development costs | 83.18%30.25M | 78.05%7.65M | 94.81%7.83M | 86.29%6.82M | 79.60%8.15M | -54.68%16.52M | -39.80%4.3M | -45.33%4.02M | -57.34%3.66M | -65.96%4.54M |
| Other operating expenses | 40.94%-1.32M | 62.40%-114.7K | ---- | -207.70%-263.14K | -62.55%-944.58K | 90.63%-2.24M | 85.88%-305.01K | 64.69%-1.27M | 98.65%-85.52K | 95.08%-581.1K |
| Operating profit | -12.70%-42.91M | 46.97%-10.01M | -112.47%-11.31M | -57.52%-10.2M | -53.89%-11.39M | -31.67%-38.08M | -140.12%-18.87M | 31.82%-5.32M | 1.01%-6.48M | -245.26%-7.4M |
| Net non-operating interest income expense | 258.79%967.6K | -83.87%65.5K | 459.87%199.14K | 701.98%281.44K | 1,325.46%421.52K | 216.99%269.68K | 803.08%406.17K | -3.93%-55.34K | 15.63%-46.75K | 46.33%-34.4K |
| Non-operating interest income | 119.84%1.29M | -71.83%136.37K | 1,829.64%277.17K | 1,211.11%374.56K | 758.61%497.89K | 723.06%584.97K | 1,517.31%484.05K | -17.38%14.36K | 80.54%28.57K | 630.97%57.99K |
| Non-operating interest expense | 0.99%318.4K | -8.99%70.88K | 11.96%78.04K | 23.63%93.12K | -17.33%76.37K | 4.54%315.28K | -11.20%77.88K | -1.31%69.7K | 5.73%75.32K | 28.27%92.39K |
| Other net income (expense) | 278.61%7.84M | 66.93%-1.45M | 175.72%760.82K | 822.99%2.58M | 7,096.56%5.94M | -142.06%-4.39M | -6,478.39%-4.39M | -64.83%275.94K | -120.66%-357.52K | -98.95%82.59K |
| Gain on sale of security | 211.65%5.39M | 51.21%-2.31M | -96.55%6.17K | 720.10%2.22M | 6,521.24%5.47M | -146.38%-4.82M | -13,020.42%-4.73M | -77.17%178.76K | -120.66%-357.52K | -98.95%82.59K |
| Other non- operating income (expenses) | 463.70%2.45M | 153.03%855K | 676.52%754.65K | --367.83K | --475.13K | 1,189.00%435.09K | 948.52%337.91K | 6,264.31%97.18K | ---- | ---- |
| Income before tax | 19.17%-34.11M | 50.15%-11.39M | -102.84%-10.35M | -6.61%-7.34M | 31.66%-5.03M | -125.45%-42.19M | -191.21%-22.86M | 27.89%-5.1M | -41.34%-6.88M | -782.08%-7.35M |
| Income tax | ||||||||||
| Net income | 19.17%-34.11M | 50.15%-11.39M | -102.84%-10.35M | -6.61%-7.34M | 31.66%-5.03M | -125.14%-42.19M | -190.26%-22.86M | 27.89%-5.1M | -44.07%-6.88M | -845.93%-7.35M |
| Net income continuous Operations | 19.17%-34.11M | 50.15%-11.39M | -102.84%-10.35M | -6.61%-7.34M | 31.66%-5.03M | -125.14%-42.19M | -190.26%-22.86M | 27.89%-5.1M | -44.07%-6.88M | -845.93%-7.35M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 19.17%-34.11M | 50.15%-11.39M | -102.84%-10.35M | -6.61%-7.34M | 31.66%-5.03M | -125.14%-42.19M | -190.26%-22.86M | 27.89%-5.1M | -44.07%-6.88M | -845.93%-7.35M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 19.17%-34.11M | 50.15%-11.39M | -102.84%-10.35M | -6.61%-7.34M | 31.66%-5.03M | -125.14%-42.19M | -190.26%-22.86M | 27.89%-5.1M | -44.07%-6.88M | -845.93%-7.35M |
| Basic earnings per share | 51.83%-3.68 | 68.05%-1.23 | -15.46%-1.12 | 41.91%-0.79 | 63.01%-0.54 | -77.26%-7.64 | -112.71%-3.85 | 39.38%-0.97 | -23.64%-1.36 | -830.00%-1.46 |
| Diluted earnings per share | 51.83%-3.68 | 68.05%-1.23 | -15.46%-1.12 | 41.91%-0.79 | 63.01%-0.54 | -77.26%-7.64 | -112.71%-3.85 | 39.38%-0.97 | -23.64%-1.36 | -830.00%-1.46 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call